| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Accounting Officer
1 company
Hagen Brett R is a Chief Accounting Officer at Kalaris Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 16 sells.
Estimated insider holdings value: $9K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 11, 2022 | KLRS Kalaris Therapeutics, Inc. | Chief Accounting Officer | Sell | 24,000 | $8.13 | $195,182.51 | -12.4% | -29.1% | -83.3% | |
| Oct 24, 2022 | KLRS Kalaris Therapeutics, Inc. | Chief Accounting Officer | Sell | 13,679 | $8.43 | $115,297.94 | -4.2% | -30.4% | -80.7% | |
| Apr 20, 2022 | KLRS Kalaris Therapeutics, Inc. | Chief Accounting Officer | Sell | 276 | $6.68 | $1,844.87 | -0.3% | -17.9% | -39.5% | |
| Jan 20, 2022 | KLRS Kalaris Therapeutics, Inc. | Chief Accounting Officer | Sell | 1,563 | $8.75 | $13,680.31 | -2.4% | -26.4% | -38.2% | |
| Feb 22, 2021 | KLRS Kalaris Therapeutics, Inc. | Chief Accounting Officer | Sell | 800 | $43.14 | $34,509.04 | -1.2% | - | - | |
| Feb 18, 2021 | KLRS Kalaris Therapeutics, Inc. | Chief Accounting Officer | Sell | 741 | $40.11 | $29,723.67 | -0.6% | - | - | |
| Feb 17, 2021 | KLRS Kalaris Therapeutics, Inc. | Chief Accounting Officer | Sell | 5,370 | $41.26 | $221,579.49 | -1.3% | - | - |